Human microbial ecology: Lactobacilli, probiotics, selective decontamination

Anaerobe

Volumn 17, Issue 6, 2011, Pages 463-467

  Mikelsaar, Marika ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Antimicrobial treatment; Critical illness; Intestinal lactobacilli; Probiotics

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; NEOMYCIN; PROBIOTIC AGENT; QUINOLONE DERIVATIVE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLOODSTREAM INFECTION; CRITICALLY ILL PATIENT; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR ECOLOGY; NONHUMAN; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; SPECIES DIFFERENTIATION; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; BACTERIA; BIOTA; DECONTAMINATION; GASTROINTESTINAL TRACT; HUMANS; PROBIOTICS;

LACTOBACILLUS;

EID: 84655163797     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.07.005     Document Type: Short Survey

References (56)

1. Mackie R. Mutualistic fermentative digestion in the gastrointestinal tract: diversity and evolution. Integ Comp Biol 2002, 42:319-326.
2. Lay C., Rigottier-Gois L., Holmstrom K., Rajilic M., Vaughan E.E., de Vos W.M., et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005, 71:4153-4155.
3. Dethlefsen L., Eckburg P.B., Bik E.M., Relman D.A. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006, 21:517-523.
4. McFarland L. Renewed interest in a difficult disease: Clostridium difficile infections - epidemiology and current treatment strategies. Curr Op Gastroenterol 2008, 25:24-35.
5. Canny G.O., McCormick B.A. Bacteria in the intestine, helpful residents or enemies from within?. Infect Immun 2008, 76:3360-3373.
6. Guarner F. Enteric flora in health and disease. Digestion 2006, 73(Suppl. 1):5-12.
7. Andremont A. Consequences of antibiotic therapy to the intestinal ecosystem. Ann Fr Anesth Reanim 2000, 19:395-402.
8. Woodmansey E.J., McMurdo M.E., Macfarlane G.T., Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004, 70:6113-6122.
9. Zuccotti G.V., Meneghin F., Raimondi C., Dilillo D., Agostoni C., Riva E., et al. Probiotics in clinical practice: an overview. JInt Med Res 2008, 36(Suppl. 1):1A-53A.
10. Bartosch S., Fite A., Macfarlane G.T., McMurdo M.E. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004, 70:3575-3581.
11. Burlaud A., Mathieu D., Falissard B., Trivalle C. Mortality and bloodstream infections in geriatrics units. Arch Gerontol Geriatr 2010, 51:e106-e109.
12. Leibovici L., Pitlik S.D., Konisberger H., Drucker M. Bloodstream infections in patients older than eighty years. Age Ageing 1993, 22:431-442.
13. Cretel E., Veen I., Pierres A., Bongrand P., Gavazzi G. Immunosenescence and infections, myth or reality?. Med Mal Infect 2010, 40:307-318.
14. Haas L.E., Schultz M.J. Selective decontamination of the digestive tract reduces pneumonia and mortality. Crit Care Res Pract 2010, 2010:501031.
15. Mitt P., Adamson V., Loivukene K., Lang K., Telling K., Paro K., et al. Epidemiology of nosocomial bloodstream infections in Estonia. JHosp Infect 2009, 71:365-370.
16. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
17. Stoutenbeek C.P., van Saene H.K., Zandstra D.F. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. JAntimicrob Chemother 1987, 19:513-520.
18. Benus R.F., Harmsen H.J., Welling G.W., Spanjersberg R., Zijlstra J.G., Degener J.E., et al. Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intensive Care Med 2010, 36:1394-1402.
19. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
20. Solomkin J.S., Mazuski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
21. Vaughan E.E., Heilig H.G., Ben-Amor K., de Vos W.M. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 2005, 29:477-490.
22. Tannock G.W. Aspecial fondness for lactobacilli. Appl Environ Microbiol 2004, 70:3189-3194.
23. Kandler O, Weiss N. Regular Non-sporing Gram-positive Rods. 1986:1209-1234.
24. Hammes W, Vogel RF. The Genus Lactobacillus. 1995:19-54.
25. Axelsson L. Lactic acid bacteria: classification physiology. 1998:1-72.
26. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998, 44:93-106.
27. Felis G.E., Dellaglio F. Taxonomy of lactobacilli and bifidobacteria. Curr Issues Intest Microbiol 2007, 8:44-61.
28. Rettger L. Lactobacillus acidophilus. Its Therapeutic Application 1935, Yale University Press, New Haven.
29. Lerche M., Reuter G. Acontribution to the method of isolation and differentiation of aerobic "lactobacilli" (Genus "Lactobacillus Beijerinck"). Zentralbl Bakteriol 1960, 179:354-370.
30. Finegold S.M., Sutter V.L., Sugihara P.T., Elder H.A., Lehmann S.M., Phillips R.L. Fecal microbial flora in seventh day adventist populations and control subjects. Am J Clin Nutr 1977, 30:1781-1792.
31. Moore W.E., Cato E.P., Holdeman L.V. Some current concepts in intestinal bacteriology. Am J Clin Nutr 1978, 31:S33-S42.
32. Molin G., Jeppsson B., Johansson M.L., Ahrne S., Nobaek S., Stahl M., et al. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. JAppl Bacteriol 1993, 74:314-323.
33. Tannock GW. The microecology of lactobacilli inhabiting the gastrointestinal tract. 1990:147-171.
34. Ahrne S., Nobaek S., Jeppsson B., Adlerberth I., Wold A.E., Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. JAppl Microbiol 1998, 85:88-94.
35. Heilig H.G., Zoetendal E.G., Vaughan E.E., Marteau P., Akkermans A.D., de Vos W.M. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002, 68:114-123.
36. Dal Bello F., Walter J., Hammes W.P., Hertel C. Increased complexity of the species composition of lactic acid bacteria in human feces revealed by alternative incubation condition. Microb Ecol 2003, 45:455-463.
37. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 2008, 74:4985-4996.
38. Mikelsaar M., Annuk H., Stsepetova J. Intestinal lactobacilli of Estonian and Swedish children. Microb Ecol Health Dis 2002, 14:75-80.
39. Mikelsaar M., Stsepetova J., Hutt P., Kolk H., Sepp E., Loivukene K., et al. Intestinal Lactobacillus spp. is associated with some cellular and metabolic characteristics of blood in elderly people. Anaerobe 2010, 16:240-246.
40. Stsepetova J., Sepp E., Kolk H., Lõivukene K., Songisepp E., Mikelsaar M. Diversity and metabolic impact of intestinal Lactobacillus spp. in healthy adults and the elderly. Brit J Nutr 2011, 105:1235-1244.
41. Charteris W.P., Kelly P.M., Morelli L., Collins J.K. Antibiotic susceptibility of potentially probiotic Lactobacillus species. JFood Prot 1998, 61:1636-1643.
42. Mändar R., Lõivukene K., Hütt P., Karki T., Mikelsaar M. Antibacterial susceptibility of intestinal lactobacilli of healthy children. Scand J Infect Dis 2001, 33:344-349.
43. Danielsen M., Wind A. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol 2003, 82:1-11.
44. Koll P., Mandar R., Smidt I., Hutt P., Truusalu K., Mikelsaar R.H., et al. Screening and Evaluation of human intestinal lactobacilli for the development of Novel gastrointestinal probiotics. Curr Microbiol 2010, 61:560-566.
45. Jorgensen J., Turnidge J.D. Susceptibility test methods; general conditions 2003.
46. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
47. Naaber P., Klaus K., Sepp E., Bjorksten B., Mikelsaar M. Colonization of infants and hospitalized patients with Clostridium difficile and lactobacilli. Clin Infect Dis 1997, 25(Suppl. 2):S189-S190.
48. Delgado S., Suarez A., Mayo B. Dominant cultivable Lactobacillus species from the feces of healthy adults in northern Spain. Int Microbiol 2007, 10:141-145.
49. Klare I., Konstabel C., Muller-Bertling S., Reissbrodt R., Huys G., Vancanneyt M., et al. Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria. Appl Environ Microbiol 2005, 71:8982-8986.
50. Klare I., Konstabel C., Werner G., Huys G., Vankerckhoven V., Kahlmeter G., et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. JAntimicrob Chemother 2007, 59:900-912.
51. Egervärn M., Danielsen M., Roos S., Lindmark H., Lindgren S. Antibiotic susceptibility profiles of Lactobacillus reuteri and Lactobacillus fermentum. JFood Prot 2007, 70:412-418.
52. Bengmark S. Ecoimmunonutrition: a challenge for the third millennium. Nutrition 1998, 14:563-572.
53. Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 2006, 42:e35-e44.
54. Truusalu K., Mikelsaar R.H., Naaber P., Karki T., Kullisaar T., Zilmer M., et al. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 2008, 8:132.
55. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659.
56. Margolis K.L., Manson J.E., Greenland P., Rodabough R.J., Bray P.F., Safford M., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005, 165:500-508.